Cite
MLA Citation
Dominik Koeditz et al.. “Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany.” Multiple sclerosis journal, experimental, translational and clinical, vol. 8, no. 1, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100146068522.0x000036